ALFA Finder| Revenue growth | 16% YoY growth in FY26. |
|---|---|
| Margins | EBITDA margin steady at ~26.2% despite capacity expansion. |
| Demand visibility | High demand-supply gap; ~76% occupancy in FY26. |
Growth
FY26 Revenue reached ₹10,065 Cr (+16% YoY); EBITDA grew to ₹2,638 Cr (+14% YoY); PAT stood at ₹1,631 Cr (+22%).
Outlook
Adding ~4,000 beds by FY29-30; Estimated ₹6,672 Cr outflow for brownfield/greenfield projects; Target ROCE threshold 20-25% post-acquisition.
Risks
Regulatory changes in healthcare costs; competitive intensity in NCR/Mumbai; rising doctor compensation impacting direct costs.
Earnings Call filed with NSE, NSE: MAXHEALTH. Summary written with AI assistance from the document.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹926.90
- Market cap
- ₹90,218 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 65.3×Sector 54.5×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Earnings Call Transcript: Key Takeaways
Max Healthcare maintains strong momentum with 20% revenue growth, driven by rapid brownfield ramp-ups and improved ARPOB despite a 14% capacity increase.
Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY